Antiplatelet Therapy in ACS Patients: Comparing Appropriate P2Y12 Inhibition by Clopidogrel to the Use of New P2Y12 Inhibitors

Aim: In percutaneous coronary intervention (PCI)-treated acute coronary syndrome (ACS) patients on clopidogrel therapy, high on-treatment platelet adenosine diphosphate (ADP) reactivity was observed in numerous studies, with significant increases in non-fatal myocardial infarction, definite/probable...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Atheroscler Thromb
Main Authors: Ristorto, Jessica, Messas, Nathan, Marchandot, Benjamin, Kibler, Marion, Hess, Sébastien, Meyer, Nicolas, Schaeffer, Michael, Tuzin, Nicolas, Ohlmann, Patrick, Jesel, Laurence, Morel, Olivier
Formato: Artigo
Idioma:Inglês
Publicado em: Japan Atherosclerosis Society 2018
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6099071/
https://ncbi.nlm.nih.gov/pubmed/29415954
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.40584
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados